Pioneers in cancer care

The Aktis Oncology team is pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumors.

Leadership Team

Matthew Roden, PhD

President,
Chief Executive Officer

View Bio

Paul L. Feldman, PhD

Chief Scientific Officer

View Bio

Shulamit Ron-Bigger, PhD

Chief Operating Officer

View Bio

Akos Czibere, MD, PhD

Chief Medical Officer

View Bio

Tyler Benedum, PhD

Chief Technical Officer

View Bio

R&D Leaders

Lorraine Horgan

Vice President,
Head of Program Management

View Bio

Janet Horton, MD

Vice President,
Clinical Development

View Bio

Jeff Kovacs, PhD

Vice President,
Head of Biology

View Bio

Daša Lipovšek, PhD

Vice President,
Head of Lead Discovery

View Bio

Nate Demars

Executive Director,
Head of Clinical Operations

View Bio

Stanley Krystek, PhD

Executive Scientific Director

View Bio

Tiffany Wang, MD, MBA, MS

Executive Director,
Clinical Development

View Bio

Business Leaders

Karen McCarthy

Vice President,
Head of Finance

View Bio

Carlos Rodriguez

Executive Director,
Corporate Development

View Bio

CMC and Quality Leaders

Judit Bartis, PhD

Vice President,
CMC Operations

View Bio

Timothy I. Mitchell

Vice President,
Quality Assurance

View Bio

Tom Morley, PhD

Executive Director,
Radiopharmaceutical Development

View Bio

Board of Directors

Todd Foley

Co-founder and Chairman

View Bio

Helen Kim, MBA

Director

View Bio

Oleg Nodelman

Director

View Bio

Andrew Levin, MD, PhD

DIRECTOR

View Bio

Lloyd M. Segal, MBA

INDEPENDENT DIRECTOR

View Bio

Ken Herrmann, MD

Independent Director Chair, Scientific Advisory Board

View Bio

Mary Thistle

Independent Director

View Bio

Matthew Roden, PhD

Director

View Bio

James Carmichael, MD

OBSERVER

View Bio

Peter Dudek

Observer

View Bio

Lauren Lee, PhD

OBSERVER

View Bio

Kevin Raidy

OBSERVER

View Bio

Markus Reschke, PhD

OBSERVER

View Bio

Adam Schayowitz

OBSERVER

View Bio

Vish Sridharan, MD

OBSERVER

View Bio

Scientific Advisors

Ken Herrmann, MD

Independent Director Chair, Scientific Advisory Board

View Bio

Patrick Baeuerle, PhD

Co-founder & Advisor

View Bio

Pankaj Bhargava, MD

Advisor

View Bio

Erik Chelius, PhD

Advisor

View Bio

Johannes Czernin, MD

Advisor

View Bio

Germo Gericke, MD

Advisor

View Bio

Gary Glick, PhD

Advisor

View Bio

Dane Wittrup, PhD

Advisor

View Bio

Pioneers in cancer care

The Aktis Oncology team is pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumors.

Leadership Team

Matthew Roden, PhD

President, Chief Executive Officer

Paul L. Feldman, PhD

Chief Scientific Officer

Shulamit Ron-Bigger, PhD

Chief Operating Officer

Akos Czibere, MD, PhD

Chief Medical Officer

Tyler Benedum, PhD

Chief Technical Officer

R&D Leaders

Lorraine Horgan

Vice President, Head of Program Management

Janet Horton, MD

Vice President, Clinical Development

Jeff Kovacs, PhD

Vice President, Head of Biology

Daša Lipovšek, PhD

Vice President, Head of Lead Discovery

Nate Demars

Executive Director, Head of Clinical Operations

Stanley Krystek, PhD

Executive Scientific Director

Tiffany Wang, MD, MBA, MS

Executive Director, Clinical Development

Business Leaders

Karen McCarthy

Vice President, Head of Finance

Carlos Rodriguez

Executive Director, Corporate Development

CMC and Quality Leaders

Judit Bartis, PhD

Vice President, CMC Operations

Timothy I. Mitchell

Vice President, Quality Assurance

Tom Morley, PhD

Executive Director, Radiopharmaceutical Development

Board of Directors

Todd Foley

Co-founder and Chairman

Helen Kim, MBA

Director

Oleg Nodelman

Director

Andrew Levin, MD, PhD

DIRECTOR

Lloyd M. Segal, MBA

INDEPENDENT DIRECTOR

Ken Herrmann, MD

Independent Director Chair, Scientific Advisory Board

Mary Thistle

Independent Director

Matthew Roden, PhD

Director

James Carmichael, MD

OBSERVER

Peter Dudek

Observer

Lauren Lee, PhD

OBSERVER

Kevin Raidy

OBSERVER

Markus Reschke, PhD

OBSERVER

Adam Schayowitz

OBSERVER

Vish Sridharan, MD

OBSERVER

Scientific Advisors

Ken Herrmann, MD

Independent Director Chair, Scientific Advisory Board

Patrick Baeuerle, PhD

Co-founder & Advisor

Pankaj Bhargava, MD

Advisor

Erik Chelius, PhD

Advisor

President,
Chief Executive Officer

Vice President,
Head of Program Management

Vice President,
Clinical Development

Vice President,
Head of Biology

Vice President,
Head of Lead Discovery

Executive Director,
Head of Clinical Operations

Executive Director,
Clinical Development

Vice President,
Head of Finance

Executive Director,
Corporate Development

Vice President,
CMC Operations

Vice President,
Quality Assurance

Executive Director,
Radiopharmaceutical Development